Oxford Academic Aug 02 2018
Why test for both Bacterial Vaginitis and Sexually Transmitted Infections?
When it comes to Bacterial Vaginitis, Premier Genomics offers a more objective comprehensive molecular diagnostic solution for symptoms relating to vaginal infections.
Premier Genomics’ Bacterial Vaginitis (BV) test utilizes molecular based testing, which means, accurate results and the ability to “cast a wider net”. Casting a wider net refers to the ability to detect more pathogens than your standard BV test. We test for Aerobic pathogens, yeast pathogens and Sexually Transmitted Infections (STIs).
Vaginal symptoms are a leading cause of primary care visits for women. Women showing symptoms often receive laboratory testing based on clinic-specific standards of care. Thus, women seen at a family practice clinic might only receive a vaginitis workup, whereas those seen at a sexually transmitted diseases clinic could be more likely to receive only STI testing.
An article was released showing that there may be an increased coinfection rate between BV and STIs. This data suggest, as have other studies, that women with vaginitis symptoms may be at risk for an STI. 84% of women with BV report no symptoms. Using a more comprehensive BV test will aid in providers being able to accurately diagnose and treat patients.
For more information on our comprehensive BV test, click here.